# K970299: Jupiter Pta Catheters (Various)

- Pathway: 510(k) (Traditional)
- Applicant: Cordis Corp.
- Decided: Apr 24, 1997 after 87 days
- Product code: LIT (Catheter, Angioplasty, Peripheral, Transluminal)
- Device class: 2
- Regulation: 21 CFR 870.1250
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
12 later devices descend from it; 1 cites it directly.
0 of 13 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. The FDA summary names its predicate without a number.
- (no number) Jupiter PTA Catheters: named in the summary without a submission number
- (no number) Opta 5 PTA Catheters: named in the summary without a submission number
- (no number) Ultra Thin PTA Balloon Catheter: named in the summary without a submission number

## Most influential descendants
- K983055: RX Viatrac 14 Peripheral Dilatation Catheter, Model #'S 1003006-20, 1003007-20, 1003008-20, 1003009-20, 1003010-20, 1003 (1998), 11 descendants of its own
- K012050: Viatrac 14 Plus Peripheral Dilatation Catheter (2001), 7 descendants of its own
- K072798: Viatrac 14 Plus Peripheral Dilation Catheter (2008), 6 descendants of its own
- K102705: Armada 14 Pta Catheter (2010), 4 descendants of its own
- K033875: Atb All-Terrain Balloon Pta Dilatation Catheter (2004), 1 descendant of its own

## Indications for use
Jupiter PTA Catheters are designed for dilating stenotic atherosclerotic lesions in peripheral arteries (renal, popliteal, infra popliteal, femoral, and ilio femoral) and are also intended to treat obstructive lesions of native or synthetic arteriovenous dialysis fistulae.

Source page: https://510kreport.com/device/K970299
Methodology: https://510kreport.com/methodology